Clinical Trial Update: Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety of adding a boost with CXB or external beam radiotherapy to neoadjuvant chemoradiotherapy for early rectal adenocarcinoma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Rectal Neoplasms | Phase 3 | Status: ACTIVE_NOT_RECRUITING